找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Ways of Regulating Drugs in the 19th and 20th Centuries; Jean-Paul Gaudillière (Director),Volker Hess (Chai Book 2013 Palgrave Macmillan,

[復制鏈接]
樓主: fathom
31#
發(fā)表于 2025-3-26 21:28:56 | 只看該作者
32#
發(fā)表于 2025-3-27 01:33:23 | 只看該作者
Secrets, Bureaucracy, and the Public: Drug Regulation in Early 19th-Century Prussia,g drug market, and the expansion of state authority (Chauveau, 1999; Daemmrich, 2004; Bonah and Menut, 2004; L?wy and Gaudilliere, 2006). It may then seem strange to start a special volume on drug regulation with an analysis of drug approval starting in the early nineteenth century. Indeed, there ar
33#
發(fā)表于 2025-3-27 07:21:40 | 只看該作者
34#
發(fā)表于 2025-3-27 09:30:41 | 只看該作者
Professional and Industrial Drug Regulation in France and Germany: The Trajectories of Plant Extrac discussion on the effects of industrialization on drug production and sales, the reform replaced the previous system — in which new remedies required professional approval from the Académie de Médecine — by establishing an administrative procedure for securing a .. This “visa” was the political rec
35#
發(fā)表于 2025-3-27 17:38:18 | 只看該作者
36#
發(fā)表于 2025-3-27 18:56:02 | 只看該作者
Making Risks Visible: The Science, Politics, and Regulation of Adverse Drug Reactions,s linked to heart attacks. The scenarios involved in the recent cases of Baycol and Vioxx should be familiar. A novel drug passes intense regulatory scrutiny. The drug’s makers heavily promote it. Following widespread use, a previously unnoticed side effect is observed. Investigative journalists the
37#
發(fā)表于 2025-3-28 01:52:22 | 只看該作者
38#
發(fā)表于 2025-3-28 02:14:32 | 只看該作者
Regulating Drugs, Regulating Diseases: Consumerism and the US Tolbutamide Controversy,ess.* Relatively little attention has been paid to the relationship between the regulation of drug products and the epidemiology and definition of the disease categories to which they are necessarily linked. As drugs have increasingly come to define diseases, and diseases to define drugs, the regula
39#
發(fā)表于 2025-3-28 09:06:59 | 只看該作者
40#
發(fā)表于 2025-3-28 10:25:06 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 11:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
镇坪县| 武义县| 黎川县| 武宣县| 武胜县| 彰化县| 龙州县| 元谋县| 哈巴河县| 竹溪县| 桑植县| 兴隆县| 许昌县| 中方县| 芮城县| 衡阳市| 舟山市| 澜沧| 兰考县| 新平| 洪江市| 襄汾县| 平度市| 涪陵区| 滦平县| 砀山县| 永川市| 青川县| 温宿县| 抚顺市| 嘉禾县| 荣成市| 高陵县| 海林市| 澄江县| 和硕县| 武隆县| 六枝特区| 松原市| 永定县| 正定县|